A Phase 1, Randomised, Oral Dose Trial to Evaluate the Effect of Food on LEO 152020 in Healthy Adult Subjects
Latest Information Update: 24 Apr 2024
At a glance
- Drugs Izuforant (Primary)
- Indications Skin disorders
- Focus Pharmacokinetics
- Sponsors JW Pharmaceutical; LEO Pharma
Most Recent Events
- 17 Dec 2020 Status changed from recruiting to completed.
- 27 Nov 2020 Status changed from not yet recruiting to recruiting.
- 02 Oct 2020 Planned number of patients changed from 46 to 12.